Athens, GA – Abeome Corporation announced today it has been named a Georgia Bio Innovation Award Winner. Abeome is being recognized for the development and commercialization of the AbeoMouse™, and the platform’s ability to produce B-cells that surface display secreted antibodies. AbeoMouse™ is a triple transgenic mouse engineered to generate an enhanced immune response whose B-cells are engineered to never cease the affinity maturation process and to always display on their surface the antibody each secretes. AbeoMouse™ is primarily deployed to develop Abeome’s pipeline of therapeutic product candidates in Autoimmunity and Immuno-Oncology.
See here for more details: https://www.gabio.org/news/270626/Georgia-Bio-Announces-Innovation-Award-Winners.htm
About Abeome: Abeome is a privately-held antibody discovery company focused on the high throughput selection, analysis and synthesis of monoclonal antibodies with a primary objective to develop best-in-class products for the therapeutic antibody market – the fastest growing segment of global drug sales.
About Georgia Bio: Georgia Bio (GaBio), founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. Members include companies, universities, research institutions, government groups and other industry associations involved in discovery and application of life sciences products and related services that improve the health and well-being of people throughout the world.